News

CURE6d
KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety
The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...
Unraveling the G4 knot: How cells untie DNA to protect the genome
Not all DNA looks like the familiar twisted ladder. Sometimes, parts of our genetic code fold into unusual shapes. One such ...
SARS-CoV-2 protein found to spread between cells, triggering immune attack on healthy cells
A new study uncovers a surprising mechanism by which the SARS-CoV-2 virus, responsible for COVID-19, might cause ...
Tcmc To Showcase Asia's Leading Cell & Gene Therapy CDMO Capabilities At BIO International Convention
Headquartered in Hsinchu, Taiwan, tcmc is dedicated to producing high-quality CGT products. One of its key technologies is lentiviral vector (LVV) pr ...
The Lancet1d
Lurbinectedin with atezolizumab maintenance therapy in extensive-stage small-cell lung cancer
Small-cell lung cancer (SCLC) is one of the most lethal cancers, with patients diagnosed with extensive-stage small-cell lung cancer (ES-SCLC) experiencing a median survival of just 12 months after ...
Business Wire2d
U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lun…
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...
Mucopolysaccharidosis Type I: Strategic Shift Underway As Gene Therapies &And Next-Gen Erts Challenge Market Dominance
DataM Intelligence | competitive Intelligence MPS I market evolution accelerates as gene therapies and BBB-penetrant ERTs emerge, challengi ...